ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details) $ in Thousands |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
|
Sep. 25, 2025
USD ($)
|
Sep. 24, 2025
USD ($)
|
Dec. 31, 2025
USD ($)
item
|
Jan. 15, 2026
USD ($)
|
Aug. 31, 2025
shares
|
Dec. 31, 2024
USD ($)
|
|
| ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | ||||||
| Number of approved prescription drugs for dermatological conditions | item | 8 | |||||
| Cash and cash equivalents | $ 24,090 | $ 20,305 | ||||
| Working capital | 29,400 | $ 13,000 | ||||
| Maximum number of shares available for sale | shares | 3,750,000 | |||||
| Subsequent Event | ||||||
| ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | ||||||
| Maximum authorized share capital amount | $ 150,000 | |||||
| Third Amendment | SWK Funding LLC | Term loan | ||||||
| ORGANIZATION AND PLAN OF BUSINESS OPERATIONS | ||||||
| Minimum amount of revenue | $ 60,000 | $ 70,000 | $ 60,000 |
| X | ||||||||||
- Definition Amount of capital authorized to be raised in the form offering, issuance and sale by Securities and Exchange Commission. No definition available.
|
| X | ||||||||||
- Definition Maximum number of shares of common stock offered for sale by the entity under the sale agreement. No definition available.
|
| X | ||||||||||
- Definition The minimum amount of revenue measured on trailing for non-payment of principal amount. No definition available.
|
| X | ||||||||||
- Definition Number of product portfolio, number of approved prescription drugs for dermatological No definition available.
|
| X | ||||||||||
- Definition The amount of working capital of the entity as of the reporting end date. No definition available.
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|